These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20211634)

  • 41. Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting.
    Missailidis S; Thomaidou D; Borbas KE; Price MR
    J Immunol Methods; 2005 Jan; 296(1-2):45-62. PubMed ID: 15680150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Bead blot: a method for identifying ligand-protein and protein-protein interactions using combinatorial libraries of peptide ligands.
    Lathrop JT; Fijalkowska I; Hammond D
    Anal Biochem; 2007 Feb; 361(1):65-76. PubMed ID: 17188224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Basic overview of chemoinformatics.
    Engel T
    J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.
    Trujillo CA; Majumder P; Gonzalez FA; Moaddel R; Ulrich H
    J Pharm Biomed Anal; 2007 Jul; 44(3):701-10. PubMed ID: 17481842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Process optimization using combinatorial design principles: parallel synthesis and design of experiment methods.
    Gooding OW
    Curr Opin Chem Biol; 2004 Jun; 8(3):297-304. PubMed ID: 15183328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mathematics of SELEX against complex targets.
    Vant-Hull B; Payano-Baez A; Davis RH; Gold L
    J Mol Biol; 1998 May; 278(3):579-97. PubMed ID: 9600840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening of a glutamic acid-binding aptamer from arginine-modified DNA library.
    Kuwahara M; Ohsawa K; Kasamatsu T; Shoji A; Sawai H; Ozaki H
    Nucleic Acids Symp Ser (Oxf); 2005; (49):81-2. PubMed ID: 17150643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of data fusion methods in virtual screening: similarity and group fusion.
    Whittle M; Gillet VJ; Willett P; Loesel J
    J Chem Inf Model; 2006; 46(6):2206-19. PubMed ID: 17125165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. RELIC--a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites.
    Mandava S; Makowski L; Devarapalli S; Uzubell J; Rodi DJ
    Proteomics; 2004 May; 4(5):1439-60. PubMed ID: 15188413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Automation in the high-throughput selection of random combinatorial libraries--different approaches for select applications.
    Glökler J; Schütze T; Konthur Z
    Molecules; 2010 Apr; 15(4):2478-90. PubMed ID: 20428057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiobjective optimization of combinatorial libraries.
    Agrafiotis DK
    Mol Divers; 2002; 5(4):209-30. PubMed ID: 12549673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A fresh look at pharmaceutical screening library design.
    Nilakantan R; Nunn DS
    Drug Discov Today; 2003 Aug; 8(15):668-72. PubMed ID: 12927506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress in phage display: evolution of the technique and its application.
    Bratkovic T
    Cell Mol Life Sci; 2010 Mar; 67(5):749-67. PubMed ID: 20196239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of statistical binding properties of ligand population during in vitro selection based on population dynamics theory.
    Aita T; Nishigaki K; Husimi Y
    Math Biosci; 2014 Jan; 247():59-68. PubMed ID: 24239675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combinatorial chemistry: starting the second decade.
    Thorpe DS
    Pharmacogenomics J; 2001; 1(4):229-32. PubMed ID: 11908762
    [No Abstract]   [Full Text] [Related]  

  • 56. Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery.
    James W
    Curr Opin Pharmacol; 2001 Oct; 1(5):540-6. PubMed ID: 11764782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meeting report: high-throughput technologies for in vivo imaging agents.
    Gillies RJ; Hoffman JM; Lam KS; Menkens AE; Piwnica-Worms DR; Sullivan DC; Weissleder R
    Mol Imaging; 2005; 4(2):98-103. PubMed ID: 16105507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combinatorics and next-generation sequencing.
    Patterson N; Gabriel S
    Nat Biotechnol; 2009 Sep; 27(9):826-7. PubMed ID: 19741641
    [No Abstract]   [Full Text] [Related]  

  • 59. AIT Biosciences have announced an expert in ligand-binding assays as their new Senior Research Advisor.
    Attwood C
    Bioanalysis; 2012 Nov; 4(21):2554. PubMed ID: 23310975
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of transport and competition on ligand binding.
    Condat CA; Delsanto PP; Ruffino E; Perego G
    Biophys Chem; 1999 Feb; 76(3):185-98. PubMed ID: 17027464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.